The 5% compound inflation rider is, on most traditional long-term care policies, the most expensive single feature in the contract. Dropping it from 5% compound to 3% compound (or to simple, or to none) is one of the four formal alternatives a carrier offers on a rate-increase notice. It can lower the premium by 25-40% on many policies. It also concedes future daily-benefit growth, sometimes a lot of it.
The decision is rarely framed correctly in consumer-finance content. The standard framing — "5% compound is great, drop it only as a last resort" — is too coarse for the math. Whether the rider matters depends almost entirely on the policyholder's expected claim setting and the timeline to claim. Per the 2024 Genworth/CareScout Cost of Care Survey, year-over-year cost growth varied dramatically across LTC settings:
| Care setting | 2024 YoY cost growth | vs. 5% rider | vs. 3% rider |
|---|---|---|---|
| Home health aide | +3% | 5% rider outpaces costs | 3% rider tracks costs |
| Adult day care | +5% | 5% rider tracks costs | 3% rider lags 2 pts/yr |
| Nursing home (semi-private) | +7% | 5% rider lags 2 pts/yr | 3% rider lags 4 pts/yr |
| Assisted living | +10% | 5% rider lags 5 pts/yr | 3% rider lags 7 pts/yr |
| Homemaker services | +10% | 5% rider lags 5 pts/yr | 3% rider lags 7 pts/yr |
| Nursing home (private) | +9% | 5% rider lags 4 pts/yr | 3% rider lags 6 pts/yr |
The headline takeaway: 5% compound is overpowered for likely-home-health-aide claims and lagging for likely-private-nursing-home or assisted-living claims. The "drop the rider" decision should not be the same for those two policyholders.
This piece works the math at three timelines (5, 15, 25 years to claim) across three care-setting expectations, then translates into dropping-the-rider implications. It is a structural extension of Mechanism 2 in the rate-hike-letter five-options framework — which option fits which policyholder.
The math at the daily-benefit level
Start with $250/day daily benefit (a common policy amount), and project forward at three rider levels for three timelines:
| Daily benefit ($250 today) | 5% compound | 3% compound | Simple (3%, no compounding) |
|---|---|---|---|
| 5 years out | $319 | $290 | $288 |
| 15 years out | $520 | $389 | $363 |
| 25 years out | $847 | $523 | $438 |
The compounding gap widens nonlinearly with time. At 5 years, 5% compound is ~10% above 3% compound. At 25 years, 5% compound is ~62% above 3% compound. The decision to drop is more consequential the further the policyholder is from claim onset.
Three scenarios — what the rider actually buys
Drop is mathematically defensible
Margaret is 58. Her policy has $250/day, 5% compound. She projects she'll likely claim in her late 70s — 18-22 years out. Family pattern suggests in-home care will be the dominant setting. Home health aide costs grew 3% YoY in 2024 — well below her 5% rider. Reducing to 3% compound brings the rider closer to actual cost growth, saves a meaningful share of premium today, and the daily-benefit profile at claim time is roughly aligned with expected costs. Caveat: 2024's 3% growth on home health aides may be a single-year low; long-term home-care wage pressure could push it back toward the 5%+ range. The decision involves both the long-run projection and Margaret's tolerance for that uncertainty.
The middle-ground decision
Robert is 67. His policy has $250/day, 5% compound. He projects he'll claim in his mid-to-late 70s — 8-12 years out. Family history is mixed; he could end up in assisted living (10% YoY growth) or in-home care (3% growth). At 10 years out, 5% compound = $407/day; 3% compound = $336/day. The $71/day difference is meaningful at assisted living costs ($194/day equivalent based on 2024 medians) but less so for home-health-aide care ($213/day equivalent). The decision splits on which setting Robert thinks he'll need. This is the math signature where reducing to 3% compound is reasonable if the policyholder's long-term planning leans toward in-home care + family caregiver support, but lagged if assisted living becomes the actual setting.
Drop concedes near-term purchasing power
Eleanor is 78. Her policy has $250/day, 5% compound. Health trajectory suggests claim within 3-5 years. Projected setting: assisted living transitioning to nursing home. Nursing home semi-private grew 7% YoY in 2024; private grew 9%. Even at 5% compound, her daily benefit is already lagging actual nursing-home cost growth. Dropping to 3% compound means the daily-benefit shortfall at claim time is materially larger. For Eleanor, the 5% rider is approaching break-even with actual costs — dropping it concedes near-term purchasing power without recapturing meaningful long-term value (because the time-to-claim is short). The math signature here argues for keeping the rider intact.
Other factors that shift the math
The setting-and-timeline math is the dominant variable, but several adjacent factors push the decision in either direction.
Premium dollar saved today vs. daily benefit conceded later. The decision is not a pure-future-value calculation; it is a cash-flow trade-off. A $400/year premium reduction today, redirected into the policyholder's investment portfolio at a 4% real return for 20 years, compounds to ~$12,000. Whether that future $12,000 is more or less valuable than the daily-benefit shortfall at claim time depends on the claim probability, the claim duration, and the cost-growth assumption. Modeling both sides matters.
Other in-force policy structure. A policyholder with a lifetime benefit period has more total benefit-pool exposure to inflation drift than a policyholder with a 3-year or 5-year benefit period. For lifetime-benefit policies, the rider has more compounding to do; for shorter-period policies, the rider has less time to compound across the claim window itself.
Hybrid product alternatives. If the policyholder is still insurable, a hybrid life/LTC product with a different inflation mechanism may be a third option beyond keeping or reducing the rider on the existing policy. The mechanics of hybrid LTC riders differ materially from traditional inflation riders; the eight mechanisms missing from the cost comparison covers how.
Claim-duration distribution. Per AAALTCI claim duration data, the average long-term care claim runs approximately 2.9 years, with a long tail driven by extended dementia care episodes. Inflation matters most for the tail-claim policyholder, less for the median-claim policyholder. The rider is partly catastrophic-protection insurance against the long-tail scenario; reducing it concedes some of that catastrophic protection.
What this looks like on a rate-hike letter
When a carrier sends a rate-increase notice, the alternatives schedule typically lays out specific reduce-benefits options including inflation-rider reductions. The carrier presents the new premium at each rider level. The policyholder's decision is structurally:
- Accept the increased premium and keep the rider as-issued
- Reduce the rider (5% compound → 3% compound or simple) and bring the premium back near the pre-increase level
- Combine rider reduction with another reduction (shorter benefit period, lower daily benefit) for a larger premium decrease
- Pursue contingent nonforfeiture (where eligible) or another path on the alternatives schedule
Options 1 and 2 are the most common policyholder choices. The math above informs option 2 specifically. The full menu of decisions on a rate-hike letter is in The LTC Rate-Hike Letter: Five Options Inside the Decision Window.
Considerations to evaluate
Editorial advisory, not personal advice. The information below is what a policyholder should review with a qualified independent advisor before changing the inflation rider on an existing policy.
- Policyholder's expected claim setting. The 2024 Cost of Care Survey shows wide variance by setting. Home-health-aide claims face different inflation pressure than nursing-home claims. The setting expectation is a function of family history, current health trajectory, geographic location (cost of care varies materially by metro), and care preferences.
- Years to expected claim onset. The compounding gap between 5% and 3% widens nonlinearly with time. The decision is more consequential at long horizons.
- Cumulative premium savings vs. daily-benefit shortfall. Both sides need to be modeled. Premium saved is real; daily-benefit conceded is real. Comparing them requires a care-setting and timeline assumption.
- Claim-duration profile. Median claims run ~2.9 years. Tail claims run materially longer. The rider matters more for tail claims.
- Other reduce-benefits options on the rate-hike letter. Reducing the inflation rider alone may not be the right answer; reducing the benefit period or combining changes may produce a better trade-off.
- Policy benefit-period structure. Lifetime benefit policies have more inflation exposure than fixed-period policies.
- Insurability for hybrid alternatives. If insurable, a hybrid product may offer a different path than rider reduction on the existing policy.
The 5% compound rider is not universally "great" or universally "expensive overhead." It is well-priced for some claim settings and poorly-priced for others. The decision to keep or reduce it is a math problem with a setting-specific answer.
Primary sources
- Genworth Financial and CareScout. 2024 Cost of Care Survey, released March 2025. National median annual costs and year-over-year growth rates by care setting. carescout.com/cost-of-care
- American Association for Long-Term Care Insurance. Long-Term Care Insurance Sourcebook — average claim duration statistics. aaltci.org
- NAIC Long-Term Care Insurance Model Regulation — inflation rider specifications and reduce-benefits options on rate-increase notices.